SOPHiA GENETICS S.A.
NASDAQ: SOPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Jurgi Camblong
- Employees
- 423
- Headquarters
- Rolle, Switzerland
- IPO year
- 2021
- Market cap
- $395.6M
- Website
- https://www.sophiagenetics.com
Loading SOPH…
Loading profile data…Frequently asked questions about SOPH
What does SOPHiA GENETICS S.A. (SOPH) do?
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its rel...
Where does SOPH trade?
SOPHiA GENETICS S.A. (SOPH) trades on the NASDAQ Global Select.
What sector is SOPH in?
SOPHiA GENETICS S.A. (SOPH) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of SOPHiA GENETICS S.A.?
Jurgi Camblong is the chief executive officer of SOPHiA GENETICS S.A. (SOPH).
Where is SOPHiA GENETICS S.A. headquartered?
SOPHiA GENETICS S.A. is headquartered in Switzerland.
Does SOPH pay a dividend?
SOPHiA GENETICS S.A. (SOPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SOPH go public?
SOPHiA GENETICS S.A. (SOPH) completed its initial public offering in 2021.